Patient Recruitment Driving Length and Cost of Oncology Clinical Trials
As prospective oncology drugs progress from Phase I to Phase III clinical trials, the difference between projected and actual patient…
As prospective oncology drugs progress from Phase I to Phase III clinical trials, the difference between projected and actual patient…
The subject of pharmaceutical photostability testing often raises many questions for several reasons. Predominantly governed by ICH Guideline Q1B for…
In Adding New and Improved Attributes to Existing Drug Formulations, and Offering Opportunities for New Delivery System Development Jaypreet Dhillon,…
Since the concept of mucoadhesion was pioneered in the early 1980s, various attempts have been made to improve the adhesive…
Quantitative whole-body autoradiography (QWBA), which has brought many improvements to the realm of tissue distribution, has itself been improved recently…
The previous article examined how drug development has changed over the last century, whilst highlighting the theme of the increased…
Research regulations worldwide aim to prevent research injuries, as well as to provide remedies for injuries suffered by research participants,…
After nearly four decades in the pipeline, the countries of the European Union have finally signed an agreement that is…
On 19 February 2013, 24 EU member states signed a supra-national agreement which is intended to bring into being a…
Globalisation and other recent developments such as stricter quality control criteria, evolving technologies, and the increasing stringency of regulatory standards,…